Works matching DE "EPIDERMAL growth factor receptors"
Results: 5000
A Drug–Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non–Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 252, doi. 10.1002/cpdd.1500
- By:
- Publication type:
- Article
The role of PD-L1 in EGFR-mutant non-small cell lung cancer.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02089-y
- By:
- Publication type:
- Article
Targeting HER2 in Gastroesophageal Cancer: A New Appetite for an Old Plight: Targeting HER2 in Gastroesophageal Cancer: A. Cammarota et al.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 361, doi. 10.1007/s40265-024-02132-2
- By:
- Publication type:
- Article
Multi-gene panel sequencing reveals the relationship between driver gene mutation and clinical characteristics in lung adenocarcinoma.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02008-1
- By:
- Publication type:
- Article
Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 5, p. 508, doi. 10.3390/medicina57050508
- By:
- Publication type:
- Article
Efficient delivery of anlotinib and radioiodine by long circulating nano-capsules for active enhanced suppression of anaplastic thyroid carcinoma.
- Published in:
- Journal of Nanobiotechnology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12951-025-03223-2
- By:
- Publication type:
- Article
An update on metastatic breast cancer New targeted therapies.
- Published in:
- Medicine Today, 2024, v. 25, n. 8, p. 51
- By:
- Publication type:
- Article
Keratinocyte skin cancers Updates on diagnosis and management.
- Published in:
- Medicine Today, 2024, v. 25, n. 8, p. 21
- By:
- Publication type:
- Article
Dermatologic Adverse Events Following Afatinib in a Woman with Non-Small-Cell Lung Cancer: A Case Report.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2025, v. 18, p. 151, doi. 10.2147/CCID.S490820
- By:
- Publication type:
- Article
Interaction between Estrogen Receptors and p53: A Broader Role for Tamoxifen?
- Published in:
- Endocrinology, 2025, v. 166, n. 3, p. 1, doi. 10.1210/endocr/bqaf020
- By:
- Publication type:
- Article
Triple-positive breast cancer: navigating heterogeneity and advancing multimodal therapies for improving patient outcomes.
- Published in:
- Cancer Cell International, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12935-025-03680-7
- By:
- Publication type:
- Article
Case report: A patient with EGFR L861Q positive adenosquamous lung carcinoma transforming into large cell neuroendocrine cancer after treatment with Almonertinib.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1453066
- By:
- Publication type:
- Article
Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13775-z
- By:
- Publication type:
- Article
Mechanistic Regulation of Epidermal Growth Factor and Hormonal Receptors by Kinase Inhibitors and Organofluorines in Breast Cancer Therapy.
- Published in:
- Cell Biochemistry & Biophysics, 2025, v. 83, n. 1, p. 1113, doi. 10.1007/s12013-024-01546-9
- By:
- Publication type:
- Article
Pyrotinib-assisted whole brain radiotherapy alleviates HER2-positive advanced breast cancer and brain metastases: a prospective study in patients.
- Published in:
- Frontiers in Neurology, 2025, p. 1, doi. 10.3389/fneur.2025.1439028
- By:
- Publication type:
- Article
Is ADC a rising star in solid tumor? An umbrella review of systematic reviews and meta-analyses.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13726-8
- By:
- Publication type:
- Article
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-up.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13703-1
- By:
- Publication type:
- Article
Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.
- Published in:
- Acta Neuropathologica Communications, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40478-025-01965-6
- By:
- Publication type:
- Article
Case report: Aumolertinib plus gumarontinib in a patient with EGFR mutated non-small-cell lung cancer harboring acquired MET amplification following progression on afatinib plus crizotinib.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Edible Bird's Nest (EBN) Ameliorates the Effects of Indomethacin (IMC)-Induced Embryo Implantation Dysfunction in Rats.
- Published in:
- Biology (2079-7737), 2025, v. 14, n. 2, p. 159, doi. 10.3390/biology14020159
- By:
- Publication type:
- Article
Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 270, doi. 10.3390/ph18020270
- By:
- Publication type:
- Article
Osimertinib in the Treatment of Epidermal Growth Factor Receptor-Mutant Early and Locally Advanced Stages of Non-Small-Cell Lung Cancer: Current Evidence and Future Perspectives.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 668, doi. 10.3390/cancers17040668
- By:
- Publication type:
- Article
WBP5 Expression Influences Prognosis and Treatment Response in Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 587, doi. 10.3390/cancers17040587
- By:
- Publication type:
- Article
Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the EGFR Gene.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 563, doi. 10.3390/cancers17040563
- By:
- Publication type:
- Article
Design, Synthesis, In Vitro Anticancer and ADMET Studies of Piperazine-Pyrazolo-Quinoxalin-2(1H)-one Conjugate as EGFR Targeting Agents.
- Published in:
- Russian Journal of General Chemistry, 2025, v. 95, n. 1, p. 184, doi. 10.1134/S1070363224610366
- By:
- Publication type:
- Article
EGFR -Mutant Lung Adenocarcinoma Cell-Derived Exosomal miR-651-5p Induces CD8+ T Cell Apoptosis via Downregulating BCL2 Expression.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 482, doi. 10.3390/biomedicines13020482
- By:
- Publication type:
- Article
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 470, doi. 10.3390/biomedicines13020470
- By:
- Publication type:
- Article
Exploring CAR-PBMCs: A Novel Strategy Against EGFR-Positive Tumor Cells.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 264, doi. 10.3390/biomedicines13020264
- By:
- Publication type:
- Article
The Role of Clinicopathological Features in Tyrosine Kinase Inhibitory Duration in EGFR Mutant Metastatic Non-Small Cell Lung Cancer.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1149, doi. 10.3390/jcm14041149
- By:
- Publication type:
- Article
Downregulation of Rad51 Expression and Activity Potentiates the Cytotoxic Effect of Osimertinib in Human Non-Small Cell Lung Cancer Cells.
- Published in:
- Chemotherapy (0009-3157), 2025, v. 70, n. 1, p. 12, doi. 10.1159/000540867
- By:
- Publication type:
- Article
Corrigendum: Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1458374
- By:
- Publication type:
- Article
Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1555074
- By:
- Publication type:
- Article
The Drosophila epidermal growth factor receptor pathway regulates Hedgehog signalling and cytoneme behaviour.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-57162-5
- By:
- Publication type:
- Article
Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study).
- Published in:
- Current Oncology, 2025, v. 32, n. 2, p. 57, doi. 10.3390/curroncol32020057
- By:
- Publication type:
- Article
Spread through air spaces may predict early progression after salvage surgery for EGFR-mutant advanced lung adenocarcinoma treated with targeted therapy.
- Published in:
- World Journal of Surgical Oncology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12957-025-03707-3
- By:
- Publication type:
- Article
An Unusual Case of Metastatic Gastric Cancer Presenting with Right Heart Failure and Cardiac Metastasis.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Identification of the B7-H3 Interaction Partners Using a Proximity Labeling Strategy.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1731, doi. 10.3390/ijms26041731
- By:
- Publication type:
- Article
Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1559, doi. 10.3390/ijms26041559
- By:
- Publication type:
- Article
Single-Cell RNA Sequencing in Unraveling Acquired Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: New Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1483, doi. 10.3390/ijms26041483
- By:
- Publication type:
- Article
Exploring new frontiers in oncofertility preservation: a case of ovarian stimulation during pregnancy.
- Published in:
- Journal of Ovarian Research, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13048-025-01615-4
- By:
- Publication type:
- Article
A sequencing-based screening method identifies regulators of EGFR signaling from nonviable mutants in Caenorhabditis elegans.
- Published in:
- Science Signaling, 2025, v. 18, n. 875, p. 1, doi. 10.1126/scisignal.adp9377
- By:
- Publication type:
- Article
Presentation and management of female breast cancer in Egypt.
- Published in:
- Eastern Mediterranean Health Journal, 2022, v. 28, n. 10, p. 725, doi. 10.26719/emhj.22.076
- By:
- Publication type:
- Article
Comparison of Mast Cell Density and Prognostic Factors in Invasive Breast Carcinoma: A Single-Centre Study in Malaysia.
- Published in:
- Malaysian Journal of Medical Sciences, 2023, v. 30, n. 5, p. 81, doi. 10.21315/mjms2023.30.5.7
- By:
- Publication type:
- Article
Reduction of endocytosis and EGFR signaling is associated with the switch from isolated to clustered apoptosis during epithelial tissue remodeling in Drosophila.
- Published in:
- PLoS Biology, 2024, v. 22, n. 10, p. 1, doi. 10.1371/journal.pbio.3002823
- By:
- Publication type:
- Article
Wnt signaling modulates the response to DNA damage in the Drosophila wing imaginal disc by regulating the EGFR pathway.
- Published in:
- PLoS Biology, 2024, v. 22, n. 7, p. 1, doi. 10.1371/journal.pbio.3002547
- By:
- Publication type:
- Article
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 284, doi. 10.1111/vco.12976
- By:
- Publication type:
- Article
Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 753, doi. 10.1111/vco.12603
- By:
- Publication type:
- Article
Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 664, doi. 10.1111/vco.12590
- By:
- Publication type:
- Article
Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 1, p. 9, doi. 10.1111/vco.12554
- By:
- Publication type:
- Article